Track the 동구바이오제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 동구바이오제약 has logged 59 public disclosures. Market capitalisation: €98bn. The latest transaction was reported on 15 July 2026 (Sale). Among the most active insiders: 조용준. Every trade is openly available.
56
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
17 ops.
Sell Volume
Fundamental score
Ranked 4,295 of 29,063 companies
70.2
score / 100
Value
68
Quality
72
FCF yld-25%
Earn yld51%
EV/EBITDA3.1x
ROE·
Gross mgn60%
Net mgn21%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.